Wolverine Trading, LLC Nektar Therapeutics Call Options Transaction History

Wolverine Trading, LLC

$97.8 Billion
Q1 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	BUY	$0.53 - $1.03 $6,201 - $12,051	11,700 New	11,700 $6,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $6,688 - $11,308	2,200 Added 9.61%	25,100 $76,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $47,867 - $93,167	-15,100 Reduced 39.74%	22,900 $91,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $17,888 - $58,996	4,300 Added 12.76%	38,000 $212,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $245,841 - $417,907	-22,700 Reduced 40.25%	33,700 $472,000

Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $479,669 - $691,428	36,700 Added 186.29%	56,400 $1.01 Million
Q2 2021 Aug 06, 2021	SELL	$16.52 - $20.4 $26,432 - $32,639	-1,600 Reduced 7.51%	19,700 $343,000
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $622,656 - $957,296	-37,600 Reduced 63.84%	21,300 $416,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $203,433 - $245,487	12,900 Added 28.04%	58,900 $1.06 Million
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $19,908 - $29,748	-1,200 Reduced 2.54%	46,000 $777,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $433,302 - $602,408	25,700 Added 119.53%	47,200 $1.06 Million
Q1 2020 May 11, 2020	SELL	$14.47 - $27.96 $535,390 - $1.03 Million	-37,000 Reduced 63.25%	21,500 $388,000
Q4 2019 Feb 12, 2020	BUY	$15.87 - $23.12 $306,291 - $446,216	19,300 Added 49.23%	58,500 $1.22 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $235,049 - $504,153	13,900 Added 54.94%	39,200 $702,000
Q2 2019 Aug 20, 2019	BUY	$31.0 - $36.3 $114,700 - $134,310	3,700 Added 17.13%	25,300 $900,000
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $843,186 - $1.24 Million	-26,700 Reduced 55.28%	21,600 $726,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $416,891 - $776,105	-13,700 Reduced 22.1%	48,300 $1.62 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $436,724 - $643,806	9,400 Added 17.87%	62,000 $3.78 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $132,020 - $249,412	2,300 Added 4.57%	52,600 $5.59 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $412,058 - $1.08 Million	-17,900 Reduced 26.25%	50,300 $3 Million
Q3 2017 Nov 15, 2017	BUY	$17.79 - $24.0 $1.21 Million - $1.64 Million	68,200	68,200 $1.64 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$23.7 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$15.5 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$9.76 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.99 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$7.58 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account